Silver Book Fact

Antihypertensive therapy has been associated in clinical trials with a 1/3 reduction in stroke incidence, a 1/4 reduction in myocardical infarctions and a more than 1/2 reduction in heart failure.

Chobanian, Aram, George Bakris, Henry Black, William Cushman, Lee Green, Joseph Izzo, Daniel Jones, Barry Materson, Suzanne Oparil, Jackson Wright, and Edward Roccella. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Hypertension. 2003; 42(6): 1206-52. https://jamanetwork.com/journals/jama/article-abstract/196589?redirect=true

Reference

Title
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure
Publication
Hypertension
Publication Date
2003
Authors
Chobanian, Aram, George Bakris, Henry Black, William Cushman, Lee Green, Joseph Izzo, Daniel Jones, Barry Materson, Suzanne Oparil, Jackson Wright, and Edward Roccella
Volume & Issue
Volume 42, Issue 6
Pages
1206-52
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Development of a neuroprotective drug could potentially reduce disability from stroke by 50%.  
  • Adjusted-dose warfarin reduced stroke risk in AFib patients
    Meta-analysis of randomized trials found that adjusted-dose warfarin reduced stroke risk in atrial fibrillation patients by 60%. Antiplatelet agents reduced risk by 20%.  
  • TAVR Procedures 2011 – 2015
    From approval in 2011 through 2015, >54,000 transcatheter aortic valve replacements (TAVRs) were performed in 418 centers in 48 states.  
  • “Although high cholesterol was recognized as a key risk factor for cardiovascular disease in the 1970s, there were no good ways to reduce it. The best drug available was…  
  • Direct thrombin inhibitor reduced relative risk of venous thromboembolism
    An investigational direct thrombin inhibitor reduced relative risk of venous thromboembolism after total hip replacement surgery by 65.7%—compared to a currently available treatment.